NIVF · NewGenIvf Group Ltd
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-08-17 | Siu Wing Fung Alfred |
Director, Chairman & CEO |
Award↑
Filing footnotes — Stock Options (Right to Buy) (Direct)
Reflects the grant of stock options to acquire 272,140 Class B Ordinary Shares of the Issuer at an exercise price of US$0.0001 per share, made pursuant to the Issuer's 2024 Share Incentive Plan and the Employee Stock Option Agreement, dated August 17, 2026, between the Issuer and the Reporting Person (the "Option Agreement"). The options vest upon grant and expire on August 17, 2033 (Grant Date + 7 years), subject to earlier termination as provided in the Option Agreement and the Plan. |
Stock Options (Right to Buy)
|
272,140 |
| 2026-08-17 | Fong Hei Yue Tina |
Director, Chief Marketing Officer |
Award↑
Filing footnotes — Stock Options (Right to Buy) (Direct)
Reflects the grant of stock options to acquire 272,140 Class B Ordinary Shares of the Issuer at an exercise price of US$0.0001 per share, made pursuant to the Issuer's 2024 Share Incentive Plan and the Employee Stock Option Agreement, dated August 17, 2026, between the Issuer and the Reporting Person (the "Option Agreement"). The options vest upon grant and expire on August 17, 2033 (Grant Date + 7 years), subject to earlier termination as provided in the Option Agreement and the Plan. |
Stock Options (Right to Buy)
|
272,140 |
| 2026-07-08 | Fong Hei Yue Tina |
Director, Chief Marketing Officer |
Award↑
Filing footnotes — Employee Share Options (Direct)
The Employee Share Options were granted pursuant to the Issuer's 2024 Share Incentive Plan and an employee share option agreement, dated July 8, 2026, between the Issuer and the Reporting Person (the "Option Agreement"). The Employee Share Options vest monthly, over 36 months, with the first tranche of 10% vesting on August 8, 2026. Thereafter, the Employee Share Options vest monthly in tranches of approximately 2.6%. |
Employee Share Options
|
73,647 |
| 2026-07-08 | Siu Wing Fung Alfred |
Director, Chairman & CEO |
Award↑
Filing footnotes — Employee Share Options (Direct)
The Employee Share Options were granted pursuant to the Issuer's 2024 Share Incentive Plan and an employee share option agreement, dated July 8, 2026, between the Issuer and the Reporting Person (the "Option Agreement"). The Employee Share Options vest monthly, over 36 months, with the first tranche of 10% vesting on August 8, 2026. Thereafter, the Employee Share Options vest monthly in tranches of approximately 2.6%. |
Employee Share Options
|
73,647 |
| 2026-06-04 | Siu Wing Fung Alfred |
Director, Chairman & CEO |
Convert↑
Filing footnotes — Class B Ordinary Shares (Direct)
The Class B Ordinary Shares were acquired through the exercise of vested stock options ("Options"). The Options were granted pursuant to the Issuer's 2024 Share Incentive Plan and the employee share option agreement, dated 4 May 2026, between the Issuer and the Reporting Person (the "Option Agreement"). The options were accelerated by resolution of the independent directors of the Board of Directors on 26 May 2026, and were exercised by the Reporting Person on 4 June 2026. |
Class B Ordinary Shares
|
56,851 |
| 2026-06-04 | HRT FINANCIAL LP |
10% Owner |
Sell↓
|
Common Stock
|
64,945 |
| 2026-06-04 | Fong Hei Yue Tina |
Director, Chief Marketing Officer |
Convert↑
Filing footnotes — Class B Ordinary Shares (Direct)
The Class B Ordinary Shares were acquired through the exercise of vested stock options ("Options"). The Options were granted pursuant to the Issuer's 2024 Share Incentive Plan and the employee share option agreement, dated 4 May 2026, between the Issuer and the Reporting Person (the "Option Agreement"). The options were accelerated by resolution of the independent directors of the Board of Directors on 26 May 2026, and were exercised by the Reporting Person on 4 June 2026. |
Class B Ordinary Shares
|
56,851 |
| 2026-06-03 | HRT FINANCIAL LP |
10% Owner |
Buy↑
|
Common Stock
|
11,738 |
| 2026-06-02 | HRT FINANCIAL LP |
10% Owner |
Buy↑
|
Common Stock
|
23,018 |
| 2026-05-27 | HRT FINANCIAL LP |
10% Owner |
Sell↓
|
Common Stock
|
85,317 |
| 2026-05-26 | HRT FINANCIAL LP |
10% Owner |
Buy↑
|
Common Stock
|
27,993 |
| 2026-05-22 | HRT FINANCIAL LP |
10% Owner |
Buy↑
|
Common Stock
|
137,541 |
| 2026-05-04 | Siu Wing Fung Alfred |
Director, Chairman & CEO |
Award↑
Filing footnotes — Stock Options (Right to Buy) (Direct)
Reflects the grant of stock options to acquire 56,851 Class B Ordinary Shares of the Issuer at an exercise price of US$0.0001 per share, made pursuant to the Issuer's 2024 Share Incentive Plan and the Employee Stock Option Agreement, dated 4 May 2026, between the Issuer and the Reporting Person (the "Option Agreement"). The options vest as follows: 5,685 options on 4 June 2026 (First Tranche); 1,462 options on the 4th day of each month from 4 July 2026 through 4 April 2029 (34 monthly tranches); and 1,458 options on 4 May 2029 (Final Tranche). The options expire on 4 May 2033, subject to earlier termination as provided in the Option Agreement and the Plan. |
Stock Options (Right to Buy)
|
56,851 |
| 2026-05-04 | Fong Hei Yue Tina |
Director, Chief Marketing Officer |
Award↑
Filing footnotes — Stock Options (Right to Buy) (Direct)
Reflects the grant of stock options to acquire 56,851 Class B Ordinary Shares of the Issuer at an exercise price of US$0.0001 per share, made pursuant to the Issuer's 2024 Share Incentive Plan and the Employee Stock Option Agreement, dated 4 May 2026, between the Issuer and the Reporting Person (the "Option Agreement"). The options vest as follows: 5,685 options on 4 June 2026 (First Tranche); 1,462 options on the 4th day of each month from 4 July 2026 through 4 April 2029 (34 monthly tranches); and 1,458 options on 4 May 2029 (Final Tranche). The options expire on 4 May 2033, subject to earlier termination as provided in the Option Agreement and the Plan. |
Stock Options (Right to Buy)
|
56,851 |